BROWN REGINA purchased 384.6% of their position (5K shares) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. on the open market
Open‑market purchase worth $2.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/22/2022ACC: 0001493152-22-033261
Director
Since May 2011
+5K
Net shares
Net buyer
$2.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.40K
Price / share
$0.57
Trade value
$1.37K
% of position
184.6%
11/21/2022
1.30K→3.70K
Common Stock
Direct
Shares
+2.60K
Price / share
$0.58
Trade value
$1.51K
% of position
70.3%
11/21/2022
3.70K→6.30K
Total
Net shares
+5K
Net value
$2.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2022 | P · Purchase | +2.40K | $0.57 | $1.37K | 184.6% | 1.30K | 3.70K |
| Common Stock Direct | 11/21/2022 | P · Purchase | +2.60K | $0.58 | $1.51K | 70.3% | 3.70K | 6.30K |
| Total | +5K | $2.88K | ||||||
Derivative Transactions0
No derivative transactions reported